The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review

Tippett, V.L. orcid.org/0000-0003-1601-3546, Tattersall, L. orcid.org/0000-0001-8835-0627, Ab Latif, N.B. orcid.org/0000-0003-1499-9049 et al. (3 more authors) (2023) The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review. Oncogene, 42 (4). pp. 259-277. ISSN 0950-9232

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2022 The Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Humans; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Clinical Relevance; Doxorubicin; Neoplasm Recurrence, Local; Osteosarcoma; Drug Resistance; Neoplasm; Bone cancer; Cancer models
Dates:
  • Accepted: 26 October 2022
  • Published (online): 25 November 2022
  • Published: 20 January 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 17 Feb 2023 16:15
Last Modified: 17 Feb 2023 16:15
Status: Published
Publisher: Springer Science and Business Media LLC
Refereed: Yes
Identification Number: https://doi.org/10.1038/s41388-022-02529-x
Related URLs:

Export

Statistics